Compound heterozygosity of Hb Hamilton and de novo mutated HbM Saskatoon. 2010

Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003490 Cyanosis A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule. Cyanoses
D005260 Female Females
D006455 Hemoglobins, Abnormal Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains. Abnormal Hemoglobins
D006580 Genetic Carrier Screening Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE. Carriers, Genetic, Detection,Genetic Carriers, Detection,Heterozygote Detection,Carrier Detection, Genetic,Detection, Genetic Carrier,Genetic Carrier Detection,Heterozygote Screening,Carrier Screening, Genetic,Detection, Heterozygote,Screening, Genetic Carrier,Screening, Heterozygote,Screenings, Genetic Carrier

Related Publications

Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber
January 1991, Hemoglobin,
Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber
March 2003, Haematologica,
Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber
October 2010, The journal of obstetrics and gynaecology research,
Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber
November 1999, Hemoglobin,
Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber
November 2008, Sultan Qaboos University medical journal,
Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber
March 2002, British journal of haematology,
Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber
December 2023, Hematology, transfusion and cell therapy,
Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber
January 2022, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber
August 1966, Klinische Wochenschrift,
Saskia Brunner-Agten, and Martin Hergersberg, and Roberto Herklotz, and Andreas Hirt, and Andreas R Huber
August 2001, Hemoglobin,
Copied contents to your clipboard!